thiazolyl blue has been researched along with Sarcoma, Ewing in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boerman, OC; Fleuren, ED; Flucke, UE; Leenders, WP; Roeffen, MH; Schreuder, HW; van der Graaf, WT; Versleijen-Jonkers, YM; Vlenterie, M | 1 |
Erlacher, M; Hilger, RA; Khanna, C; Konanz, C; Kontny, U; Lissat, A; Mendoza, A; Niemeyer, CM; Reichardt, W; Uhl, M; Werner, S | 1 |
2 other study(ies) available for thiazolyl blue and Sarcoma, Ewing
Article | Year |
---|---|
Expression and clinical relevance of MET and ALK in Ewing sarcomas.
Topics: Adolescent; Adult; Anaplastic Lymphoma Kinase; Anilides; Child; Child, Preschool; Chromosome Aberrations; Crizotinib; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Inhibitory Concentration 50; Male; Middle Aged; Neoplasm Metastasis; Proto-Oncogene Proteins c-met; Pyrazoles; Pyridines; Pyrimidines; Receptor Protein-Tyrosine Kinases; Recurrence; Sarcoma, Ewing; Tetrazolium Salts; Thiazoles; Treatment Outcome; Young Adult | 2013 |
Preclinical studies of treosulfan demonstrate potent activity in Ewing's sarcoma.
Topics: Animals; Annexin A5; Antineoplastic Agents, Alkylating; Apoptosis; Bisbenzimidazole; Blotting, Western; Busulfan; Caspase 3; Cell Cycle; Cell Line, Tumor; Cell Survival; Coloring Agents; G1 Phase; Indicators and Reagents; Injections, Intraperitoneal; Mice; Mice, Nude; Sarcoma, Ewing; Tetrazolium Salts; Thiazoles; Xenograft Model Antitumor Assays | 2008 |